Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations
Open accessThe DOI matches its Crossref record; 191 of the 192 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The discovery of the CRISPR/Cas system and its development into a powerful genome engineering tool have revolutionized the field of molecular biology and generated excitement for its potential to treat a wide range of human diseases. As a gene therapy target, the retina offers many advantages over other tissues because of its surgical accessibility and relative immunity privilege due to its blood–retinal barrier. These features explain the large advances made in ocular gene therapy over the past decade, including the first in vivo clinical trial using CRISPR gene-editing reagents. Although viral vector-mediated therapeutic approaches have been successful, they have several shortcomings, including packaging constraints, pre-existing anti-capsid immunity and vector-induced immunogenicity, therapeutic potency and persistence, and potential genotoxicity. The use of nanomaterials in the delivery of therapeutic agents has revolutionized the way genetic materials are delivered to cells, tissues, and organs, and presents an appealing alternative to bypass the limitations of viral delivery systems. In this review, we explore the potential use of non-viral vectors as tools for gene therapy, exploring the latest advancements in nanotechnology in medicine and focusing on the nanoparticle-mediated delivery of CRIPSR genetic cargo to the retina.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This has created a need to explore alter native non-viral vector platforms for retinal gene therapy, such as liposome-based systems and synthetic nanoparticles (Salman et al., 2022).”
From Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy (2025) · cites this paper as Salman et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Folding DNA to create nanoscale shapes and patterns
Rothemund, P. W. K. (2006) · Nature · doi:10.1038/nature04586 · Cited by 7,354
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Search-and-replace genome editing without double-strand breaks or donor DNA
Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., Raguram, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1711-4 · Cited by 4,767
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0561-9 · Cited by 2,237
Russell, S., Bennett, J., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31868-8 · Cited by 1,952
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
Localized surface plasmon resonance: Nanostructures, bioassays and biosensing—A review
Petryayeva, E., & Krull, U. J. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.08.020 · Cited by 1,379
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., et al. (2016) · Science · doi:10.1126/science.aaf8729 · Cited by 1,349
CRISPR/Cas9 in Genome Editing and Beyond
Wang, H., La Russa, M., & Qi, L. S. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014607 · Cited by 1,110
Non-syndromic retinitis pigmentosa
Verbakel, S. K., van Huet, R. A. C., Boon, C. J. F., den Hollander, A. I., Collin, R. W. J., Klaver, C. C. W., Hoyng, C. B., Roepman, R., & Klevering, B. J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.03.005 · Cited by 973
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 890
Finn, J. D., Smith, A. R., Patel, M. C., Shaw, L., Youniss, M. R., van Heteren, J., Dirstine, T., Ciullo, C., Lescarbeau, R., Seitzer, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.014 · Cited by 878
Advances in Biomaterials for Drug Delivery
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 855
(2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)00967-9 · Cited by 814
MacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62117-0 · Cited by 796
Self-citationVakulskas, C. A., Dever, D. P., Rettig, G. R., Turk, R., Jacobi, A. M., Collingwood, M. A., Bode, N. M., McNeill, M. S., Yan, S., Camarena, J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0137-0 · Cited by 782
Lee, K., Conboy, M., Park, H. M., Jiang, F., Kim, H. J., Dewitt, M. A., Mackley, V. A., Chang, K., Rao, A., Skinner, C., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0137-2 · Cited by 755
Long-Term Effect of Gene Therapy on Leber’s Congenital Amaurosis
Bainbridge, J. W. B., Mehat, M. S., Sundaram, V., Robbie, S. J., Barker, S. E., Ripamonti, C., Georgiadis, A., Mowat, F. M., Beattie, S. G., Gardner, P. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414221 · Cited by 743
A prudent path forward for genomic engineering and germline gene modification
Baltimore, D., Berg, P., Botchan, M., Carroll, D., Charo, R. A., Church, G., Corn, J. E., Daley, G. Q., Doudna, J. A., Fenner, M., et al. (2015) · Science · doi:10.1126/science.aab1028 · Cited by 733
Arias, L. S., Pessan, J. P., Vieira, A. P. M., Lima, T. M. T. D., Delbem, A. C. B., & Monteiro, D. R. (2018) · Antibiotics · doi:10.3390/antibiotics7020046 · Cited by 714
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
Maeder, M. L., Stefanidakis, M., Wilson, C. J., Baral, R., Barrera, L. A., Bounoutas, G. S., Bumcrot, D., Chao, H., Ciulla, D. M., DaSilva, J. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0327-9 · Cited by 707
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
Cheng, X., & Lee, R. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.022 · Cited by 703
DNA repair mechanisms in dividing and non-dividing cells
Iyama, T., & Wilson, D. M. (2013) · DNA Repair · doi:10.1016/j.dnarep.2013.04.015 · Cited by 697
Engineered Virus-like Particles for Efficient in Vivo Delivery of Therapeutic Proteins
Banskota, S., Raguram, A., Suh, S., Du, S. W., Davis, J. R., Choi, E. H., Wang, X., Nielsen, S. C., Newby, G. A., Randolph, P. B., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.021 · Cited by 668
Quantum dots in biomedical applications
Wagner, A. M., Knipe, J. M., Orive, G., & Peppas, N. A. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.022 · Cited by 632
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
Rosenblum, D., Gutkin, A., Kedmi, R., Ramishetti, S., Veiga, N., Jacobi, A. M., Schubert, M. S., Friedmann-Morvinski, D., Cohen, Z. R., Behlke, M. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc9450 · Cited by 614
Wei, T., Cheng, Q., Min, Y.-L., Olson, E. N., & Siegwart, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-17029-3 · Cited by 590
Direct cytosolic delivery of CRISPR/Cas9-ribonucleoprotein for efficient gene editing
Mout, R., Ray, M., Yesilbag Tonga, G., Lee, Y.-W., Tay, T., Sasaki, K., & Rotello, V. M. (2017) · ACS Nano · doi:10.1021/acsnano.6b07600 · Cited by 579
Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights
Vallet-Regí, M., Colilla, M., Izquierdo-Barba, I., & Manzano, M. (2017) · Molecules · doi:10.3390/molecules23010047 · Cited by 538
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
Gao, X., Tao, Y., Lamas, V., Huang, M., Yeh, W.-H., Pan, B., Hu, Y.-J., Hu, J. H., Thompson, D. B., Shu, Y., et al. (2018) · Nature · doi:10.1038/nature25164 · Cited by 536
Don’t edit the human germ line
Lanphier, E., Urnov, F., Haecker, S. E., Werner, M., & Smolenski, J. (2015) · Nature · doi:10.1038/519410a · Cited by 530
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
Kantor, A., McClements, M., & MacLaren, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176240 · Cited by 462
Self-citationOne-step generation of knockout pigs by zygote injection of CRISPR/Cas system
Hai, T., Teng, F., Guo, R., Li, W., & Zhou, Q. (2014) · Cell Research · doi:10.1038/cr.2014.11 · Cited by 455
Am I ready for CRISPR? A user's guide to genetic screens
Doench, J. G. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.97 · Cited by 452
Cideciyan, A. V., Jacobson, S. G., Beltran, W. A., Sumaroka, A., Swider, M., Iwabe, S., Roman, A. J., Olivares, M. B., Schwartz, S. B., Komáromy, A. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218933110 · Cited by 444
Cornerstones of CRISPR–Cas in drug discovery and therapy
Fellmann, C., Gowen, B. G., Lin, P.-C., Doudna, J. A., & Corn, J. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.238 · Cited by 443
Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus
Flannery, J. G., Zolotukhin, S., Vaquero, M. I., LaVail, M. M., Muzyczka, N., & Hauswirth, W. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6916 · Cited by 407
The rod pathway in the rabbit retina: a depolarizing bipolar and amacrine cell
Dacheux, R., & Raviola, E. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-02-00331.1986 · Cited by 406
On the role of helper lipids in lipid nanoparticle formulations of siRNA
Kulkarni, J. A., Witzigmann, D., Leung, J., Tam, Y. Y. C., & Cullis, P. R. (2019) · Nanoscale · doi:10.1039/c9nr09347h · Cited by 402
Evolution of phototransduction, vertebrate photoreceptors and retina
Lamb, T. D. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.06.001 · Cited by 397
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
Bennett, J., Ashtari, M., Wellman, J., Marshall, K. A., Cyckowski, L. L., Chung, D. C., McCague, S., Pierce, E. A., Chen, Y., Bennicelli, J. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002865 · Cited by 395
Types of bipolar cells in the mouse retina
Ghosh, K. K., Bujan, S., Haverkamp, S., Feigenspan, A., & Wässle, H. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.10985 · Cited by 378
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
Duan, L., Ouyang, K., Xu, X., Xu, L., Wen, C., Zhou, X., Qin, Z., Xu, Z., Sun, W., & Liang, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.673286 · Cited by 377
Improvement and Decline in Vision with Gene Therapy in Childhood Blindness
Jacobson, S. G., Cideciyan, A. V., Roman, A. J., Sumaroka, A., Schwartz, S. B., Heon, E., & Hauswirth, W. W. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412965 · Cited by 372
Cehajic-Kapetanovic, J., Xue, K., Martinez-Fernandez de la Camara, C., Nanda, A., Davies, A., Wood, L. J., Salvetti, A. P., Fischer, M. D., Aylward, J. W., Barnard, A. R., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0763-1 · Cited by 368
Self-citationGee, P., Lung, M. S. Y., Okuzaki, Y., Sasakawa, N., Iguchi, T., Makita, Y., Hozumi, H., Miura, Y., Yang, L. F., Iwasaki, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14957-y · Cited by 362
Lee, B., Lee, K., Panda, S., Gonzales-Rojas, R., Chong, A., Bugay, V., Park, H. M., Brenner, R., Murthy, N., & Lee, H. Y. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0252-8 · Cited by 361
Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems
Leung, A. K. K., Tam, Y. Y. C., Chen, S., Hafez, I. M., & Cullis, P. R. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b02891 · Cited by 359
Bourges, J.-L., Gautier, S. E., Delie, F., Bejjani, R. A., Jeanny, J.-C., Gurny, R., BenEzra, D., & Behar-Cohen, F. F. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1068 · Cited by 357
Modulation of membrane function by cholesterol
Yeagle, P. L. (1991) · Biochimie · doi:10.1016/0300-9084(91)90093-g · Cited by 355
Mangeot, P. E., Risson, V., Fusil, F., Marnef, A., Laurent, E., Blin, J., Mournetas, V., Massouridès, E., Sohier, T. J. M., Corbin, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07845-z · Cited by 346
Nanoparticles in the clinic: An update post COVID‐19 vaccines
Anselmo, A. C., & Mitragotri, S. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10246 · Cited by 337
Yang, W., Liang, H., Ma, S., Wang, D., & Huang, J. (2019) · Sustainable Materials and Technologies · doi:10.1016/j.susmat.2019.e00109 · Cited by 329
Li, Z., Zhang, Y., & Feng, N. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1575806 · Cited by 321
A decade of discovery: CRISPR functions and applications
Barrangou, R., & Horvath, P. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.92 · Cited by 319
Materials and methods for delivery of biological drugs
Zelikin, A. N., Ehrhardt, C., & Healy, A. M. (2016) · Nature Chemistry · doi:10.1038/nchem.2629 · Cited by 315
Bilati, U., Allémann, E., & Doelker, E. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.10.006 · Cited by 313
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Fonseca-Santos, B., Chorilli, M., & Palmira Daflon Gremião, M. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87148 · Cited by 308
Kou, L., Bhutia, Y. D., Yao, Q., He, Z., Sun, J., & Ganapathy, V. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00027 · Cited by 308
A Mouse Geneticist’s Practical Guide to CRISPR Applications
Singh, P., Schimenti, J. C., & Bolcun-Filas, E. (2015) · Genetics · doi:10.1534/genetics.114.169771 · Cited by 305
CRISPR/Cas9-based engineering of the epigenome
Pulecio, J., Verma, N., Mejía-Ramírez, E., Huangfu, D., & Raya, A. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.09.006 · Cited by 300
Chen, Z., Liu, F., Chen, Y., Liu, J., Wang, X., Chen, A. T., Deng, G., Zhang, H., Liu, J., Hong, Z., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703036 · Cited by 297
Bakondi, B., Lv, W., Lu, B., Jones, M. K., Tsai, Y., Kim, K. J., Levy, R., Akhtar, A. A., Breunig, J. J., Svendsen, C. N., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2015.220 · Cited by 296
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
Xu, X., Liu, C., Wang, Y., Koivisto, O., Zhou, J., Shu, Y., & Zhang, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113891 · Cited by 289
Near-infrared upconversion–activated CRISPR-Cas9 system: A remote-controlled gene editing platform
Pan, Y., Yang, J., Luan, X., Liu, X., Li, X., Yang, J., Huang, T., Sun, L., Wang, Y., Lin, Y., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav7199 · Cited by 271
Acoustically Active Lipospheres Containing Paclitaxel: A New Therapeutic Ultrasound Contrast Agent
UNGER, E. C., McCREERY, T. P., SWEITZER, R. H., CALDWELL, V. E., & WU, Y. (1998) · Investigative Radiology · doi:10.1097/00004424-199812000-00007 · Cited by 267
Pagon, R. A. (1988) · Survey of Ophthalmology · doi:10.1016/0039-6257(88)90085-9 · Cited by 263
Lipid nanoparticles for delivery of messenger RNA to the back of the eye
Patel, S., Ryals, R. C., Weller, K. K., Pennesi, M. E., & Sahay, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.015 · Cited by 260
Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps
Duncan, J. L., Pierce, E. A., Laster, A. M., Daiger, S. P., Birch, D. G., Ash, J. D., Iannaccone, A., Flannery, J. G., Sahel, J. A., Zack, D. J., et al. (2018) · Translational Vision Science & Technology · doi:10.1167/tvst.7.4.6 · Cited by 257
Huang, K.-W., Hsu, F.-F., Qiu, J. T., Chern, G.-J., Lee, Y.-A., Chang, C.-C., Huang, Y.-T., Sung, Y.-C., Chiang, C.-C., Huang, R.-L., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax5032 · Cited by 256
Gene transfer into the mouse retina mediated by an adeno-associated viral vector
Ali, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.5.591 · Cited by 255
Efficient Gene Knockout in Goats Using CRISPR/Cas9 System
Ni, W., Qiao, J., Hu, S., Zhao, X., Regouski, M., Yang, M., Polejaeva, I. A., & Chen, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106718 · Cited by 249
Ghazi, N. G., Abboud, E. B., Nowilaty, S. R., Alkuraya, H., Alhommadi, A., Cai, H., Hou, R., Deng, W.-T., Boye, S. L., Almaghamsi, A., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1637-y · Cited by 243
In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges
Mout, R., Ray, M., Lee, Y.-W., Scaletti, F., & Rotello, V. M. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00057 · Cited by 243
Olsen, T. W., Edelhauser, H. F., Lim, J. I., & Geroski, D. H. (1995) · PubMed · Cited by 230
Ocular delivery of proteins and peptides: Challenges and novel formulation approaches
Mandal, A., Pal, D., Agrahari, V., Trinh, H. M., Joseph, M., & Mitra, A. K. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.008 · Cited by 225
A review on recent drug delivery systems for posterior segment of eye
Nayak, K., & Misra, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.138 · Cited by 225
Weleber, R. G., Pennesi, M. E., Wilson, D. J., Kaushal, S., Erker, L. R., Jensen, L., McBride, M. T., Flotte, T. R., Humphries, M., Calcedo, R., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.03.003 · Cited by 218
Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering
Hamilton, J. R., Tsuchida, C. A., Nguyen, D. N., Shy, B. R., McGarrigle, E. R., Sandoval Espinoza, C. R., Carr, D., Blaeschke, F., Marson, A., & Doudna, J. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109207 · Cited by 208
Tight Junctions of the Outer Blood Retina Barrier
Naylor, A., Hopkins, A., Hudson, N., & Campbell, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010211 · Cited by 206
Nanoscale drug delivery systems and the blood–brain barrier
Khalin, I., Alyautdin, R., Ismail, N. M., Haron, M. H., & Kuznetsov, D. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s52236 · Cited by 204
Xu, C., Nam, J., Hong, H., Xu, Y., & Moon, J. J. (2019) · ACS Nano · doi:10.1021/acsnano.9b06691 · Cited by 198
Yao, X., Lyu, P., Yoo, K., Yadav, M. K., Singh, R., Atala, A., & Lu, B. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12076 · Cited by 194
ABRISHAMI, M., GANAVATI, S. Z., SOROUSH, D., ROUHBAKHSH, M., JAAFARI, M. R., & MALAEKEH-NIKOUEI, B. (2009) · Retina · doi:10.1097/iae.0b013e3181a2f42a · Cited by 184
Intracellular delivery of protein and peptide therapeutics
Torchilin, V. (2008) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2009.01.002 · Cited by 180
Subretinal injection: a review on the novel route of therapeutic delivery for vitreoretinal diseases
Peng, Y., Tang, L., & Zhou, Y. (2017) · Ophthalmic Research · doi:10.1159/000479157 · Cited by 175
Gene Delivery Using Ultrasound Contrast Agents
Unger, E. C., Hersh, E., Vannan, M., & McCreery, T. (2001) · Echocardiography · doi:10.1046/j.1540-8175.2001.00355.x · Cited by 170
Liu, Y., Li, K., Liu, B., & Feng, S.-S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.053 · Cited by 166
Davis, B. M., Normando, E. M., Guo, L., Turner, L. A., Nizari, S., O'Shea, P., Moss, S. E., Somavarapu, S., & Cordeiro, M. F. (2014) · Small · doi:10.1002/smll.201303433 · Cited by 164
Controlled Delivery of the Anti-VEGF Aptamer EYE001 with Poly(lactic-co-glycolic)Acid Microspheres
Carrasquillo, K. G., Ricker, J. A., Rigas, I. K., Miller, J. W., Gragoudas, E. S., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.01-1156 · Cited by 163
Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
Kim, K., Park, S. W., Kim, J. H., Lee, S. H., Kim, D., Koo, T., Kim, K.-E., Kim, J. H., & Kim, J.-S. (2017) · Genome Research · doi:10.1101/gr.219089.116 · Cited by 163
Gavini, E., Chetoni, P., Cossu, M., Alvarez, M. G., Saettone, M. F., & Giunchedi, P. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.10.018 · Cited by 160
Sahandi Zangabad, P., Karimi, M., Mehdizadeh, F., Malekzad, H., Ghasemi, A., Bahrami, S., Zare, H., Moghoofei, M., Hekmatmanesh, A., & Hamblin, M. R. (2017) · Nanoscale · doi:10.1039/c6nr07315h · Cited by 154
Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye
Loftsson, Þ., & Stefánsson, E. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.010 · Cited by 149
Liu, Q., Wang, C., Zheng, Y., Zhao, Y., Wang, Y., Hao, J., Zhao, X., Yi, K., Shi, L., Kang, C., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120275 · Cited by 148
Korenbrot, J. I. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.05.002 · Cited by 141
Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks
Song, F., & Stieger, K. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.02.006 · Cited by 140
The role of cholesterol in rod outer segment membranes
ALBERT, A., & Boesze‐Battaglia, K. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.02.001 · Cited by 138
Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus
Campbell, L. A., Coke, L. M., Richie, C. T., Fortuno, L. V., Park, A. Y., & Harvey, B. K. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.10.002 · Cited by 133
Knight, F. C., Gilchuk, P., Kumar, A., Becker, K. W., Sevimli, S., Jacobson, M. E., Suryadevara, N., Wang-Bishop, L., Boyd, K. L., Crowe, J. E., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b00326 · Cited by 133
Sedighi, M., Sieber, S., Rahimi, F., Shahbazi, M., Rezayan, A. H., Huwyler, J., & Witzigmann, D. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0587-4 · Cited by 130
Giannelli, S. G., Luoni, M., Castoldi, V., Massimino, L., Cabassi, T., Angeloni, D., Demontis, G. C., Leocani, L., Andreazzoli, M., & Broccoli, V. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx438 · Cited by 127
Khokhlova, T. D., Wang, Y.-N., Simon, J. C., Cunitz, B. W., Starr, F., Paun, M., Crum, L. A., Bailey, M. R., & Khokhlova, V. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318355111 · Cited by 125
Huu, V. A. N., Luo, J., Zhu, J., Zhu, J., Patel, S., Boone, A., Mahmoud, E., McFearin, C., Olejniczak, J., de Gracia Lux, C., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.001 · Cited by 122
Animal Models of Retinal Disease
Fletcher, E. L., Jobling, A. I., Vessey, K. A., Luu, C. D., Guymer, R. H., & Baird, P. N. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00006-6 · Cited by 119
Lyu, P., Javidi-Parsijani, P., Atala, A., & Lu, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz605 · Cited by 119
Inorganic nanosystems for therapeutic delivery: Status and prospects
Kim, C. S., Tonga, G. Y., Solfiell, D., & Rotello, V. M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.011 · Cited by 118
Rajala, A., Wang, Y., Zhu, Y., Ranjo-Bishop, M., Ma, J.-X., Mao, C., & Rajala, R. V. S. (2014) · Nano Letters · doi:10.1021/nl502275s · Cited by 117
Li, P., Kleinstiver, B. P., Leon, M. Y., Prew, M. S., Navarro-Gomez, D., Greenwald, S. H., Pierce, E. A., Joung, J. K., & Liu, Q. (2018) · The CRISPR Journal · doi:10.1089/crispr.2017.0009 · Cited by 116
Kefalov, V. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.303008 · Cited by 114
Liposomal delivery of CRISPR/Cas9
Zhen, S., & Li, X. (2019) · Cancer Gene Therapy · doi:10.1038/s41417-019-0141-7 · Cited by 114
Synaptic circuitry of the retina and olfactory bulb
DeVries, S. H., & Baylor, D. A. (1993) · Cell · doi:10.1016/s0092-8674(05)80033-9 · Cited by 113
Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
LaFountaine, J. S., Fathe, K., & Smyth, H. D. C. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.029 · Cited by 111
Young, J. L., Benoit, J. N., & Dean, D. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302021 · Cited by 109
Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward
Bennett, J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.008 · Cited by 109
Wang, Y., Shahi, P. K., Xie, R., Zhang, H., Abdeen, A. A., Yodsanit, N., Ma, Z., Saha, K., Pattnaik, B. R., & Gong, S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.052 · Cited by 107
Generation of multi-gene knockout rabbits using the Cas9/gRNA system
Yan, Q., Zhang, Q., Yang, H., Zou, Q., Tang, C., Fan, N., & Lai, L. (2014) · Cell Regeneration · doi:10.1186/2045-9769-3-12 · Cited by 101
Direct Cytosolic Delivery of siRNA Using Nanoparticle‐Stabilized Nanocapsules
Jiang, Y. Y., Tang, R., Duncan, B., Jiang, Z., Yan, B., Mout, R., & Rotello, V. M. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201409161 · Cited by 99
Park, K., Chen, Y., Hu, Y., Mayo, A. S., Kompella, U. B., Longeras, R., & Ma, J.-X. (2009) · Diabetes · doi:10.2337/db08-1327 · Cited by 97
High-purity production and precise editing of DNA base editing ribonucleoproteins
Jang, H.-K., Jo, D. H., Lee, S.-N., Cho, C. S., Jeong, Y. K., Jung, Y., Yu, J., Kim, J. H., Woo, J.-S., & Bae, S. (2021) · Science Advances · doi:10.1126/sciadv.abg2661 · Cited by 93
Benedicto, I., Lehmann, G. L., Ginsberg, M. D., Nolan, D. J., Bareja, R., Elemento, O., Salfati, Z., Alam, N. M., Prusky, G. T., Llanos, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms15374 · Cited by 92
Jose, S., Cinu, T. A., Sebastian, R., Shoja, M. H., Aleykutty, N. A., Durazzo, A., Lucarini, M., Santini, A., & Souto, E. B. (2019) · Polymers · doi:10.3390/polym11111905 · Cited by 91
Nanotechnology-Based Strategies to Overcome Current Barriers in Gene Delivery
Mirón-Barroso, S., Domènech, E. B., & Trigueros, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168537 · Cited by 91
Self-citationWang, J., Potocny, A. M., Rosenthal, J., & Day, E. S. (2020) · ACS Omega · doi:10.1021/acsomega.9b04150 · Cited by 88
Transfection by particle bombardment: Delivery of plasmid DNA into mammalian cells using gene gun
Uchida, M., Li, X. W., Mertens, P., & Alpar, H. O. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.05.013 · Cited by 87
Li, H., Tran, V. V., Hu, Y., Saltzman, W. M., Barnstable, C. J., & Tombran‐Tink, J. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.04.014 · Cited by 86
Cai, Y., Cheng, T., Yao, Y., Li, X., Ma, Y., Li, L., Zhao, H., Bao, J., Zhang, M., Qiu, Z., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav3335 · Cited by 86
Sarfraz, M., Afzal, A., Yang, T., Gai, Y., Raza, S. M., Khan, M. W., Cheng, Y., Ma, X., & Xiang, G. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030151 · Cited by 80
Molecular Therapies for Inherited Retinal Diseases—Current Standing, Opportunities and Challenges
Vázquez-Domínguez, I., Garanto, A., & Collin, R. W. J. (2019) · Genes · doi:10.3390/genes10090654 · Cited by 80
Wang, R., Gao, Y., Liu, A., & Zhai, G. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1878366 · Cited by 78
Oh, E. J., Choi, J.-S., Kim, H., Joo, C.-K., & Hahn, S. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.003 · Cited by 77
Nanotechnology in retinal drug delivery
Jiang, S., Franco, Y. L., Zhou, Y., & Chen, J. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.06.23 · Cited by 77
Microfluidic-assisted polymer-protein assembly to fabricate homogeneous functionalnanoparticles
Zhang, L., Beatty, A., Lu, L., Abdalrahman, A., Makris, T. M., Wang, G., & Wang, Q. (2020) · Materials Science and Engineering: C · doi:10.1016/j.msec.2020.110768 · Cited by 73
Incidence and clinical features of post-injection endophthalmitis according to diagnosis
Rayess, N., Rahimy, E., Shah, C. P., Wolfe, J. D., Chen, E., DeCroos, F. C., Storey, P. P., Garg, S. J., & Hsu, J. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-307707 · Cited by 71
Yang, T.-C., Chang, C.-Y., Yarmishyn, A. A., Mao, Y.-S., Yang, Y.-P., Wang, M.-L., Hsu, C.-C., Yang, H.-Y., Hwang, D.-K., Chen, S.-J., et al. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.10.037 · Cited by 70
Technical brief: subretinal injection and electroporation into adult mouse eyes.
Johnson, C. J., Berglin, L., Chrenek, M. A., Redmond, T. M., Boatright, J. H., & Nickerson, J. M. (2008) · PubMed Central · Cited by 69
Burke, P. A., Klumb, L. A., Herberger, J. D., Nguyen, X. C., Harrell, R. A., & Zordich, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019305.79599.a5 · Cited by 65
Oh, E. J., Park, K., Choi, J., Joo, C., & Hahn, S. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.024 · Cited by 63
Suprachoroidal gene transfer with nonviral nanoparticles
Shen, J., Kim, J., Tzeng, S. Y., Ding, K., Hafiz, Z., Long, D., Wang, J., Green, J. J., & Campochiaro, P. A. (2020) · Science Advances · doi:10.1126/sciadv.aba1606 · Cited by 63
Giannaccini, M., Giannini, M., Calatayud, M., Goya, G., Cuschieri, A., Dente, L., & Raffa, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011590 · Cited by 61
Remodeling of junctional complexes during the development of the outer blood-retinal barrier
Williams, C. D., & Rizzolo, L. J. (1997) · The Anatomical Record · doi:10.1002/(sici)1097-0185(199711)249:3<380::aid-ar9>3.0.co;2-y · Cited by 61
Chou, S., Yang, P., Ban, Q., Yang, Y., Wang, M., Chien, C., Chen, S., Sun, N., Zhu, Y., Liu, H., et al. (2020) · Advanced Science · doi:10.1002/advs.201903432 · Cited by 61
Rahner, C., Fukuhara, M., Peng, S., Kojima, S., & Rizzolo, L. J. (2004) · Journal of Cell Science · doi:10.1242/jcs.01181 · Cited by 58
Routes for Drug Delivery to the Eye and Retina: Intravitreal Injections
Meyer, C. H., Krohne, T. U., Charbel Issa, P., Liu, Z., & Holz, F. G. (2016) · Developments in Ophthalmology · doi:10.1159/000431143 · Cited by 57
Ban, Y., & Rizzolo, L. J. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.3.c744 · Cited by 56
Publisher Correction: Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2018) · Nature · doi:10.1038/s41586-018-0070-x · Cited by 56
Owen, J., Crake, C., Lee, J. Y., Carugo, D., Beguin, E., Khrapitchev, A. A., Browning, R. J., Sibson, N. R., & Stride, E. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0366-7 · Cited by 55
Apical and Basal Regulation of the Permeability of the Retinal Pigment Epithelium
Peng, S., Rahner, C., & Rizzolo, L. J. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0473 · Cited by 54
Electrically Assisted Ocular Gene Therapy
Bejjani, R. A., Andrieu‐Soler, C., Bloquel, C., Berdugo, M., BenEzra, D., & Béhar‐Cohen, F. (2007) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.12.005 · Cited by 54
Indiková, I., & Indik, S. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa561 · Cited by 52
Claudin 5 Is Transiently Expressed During the Development of the Retinal Pigment Epithelium
Kojima, S., Rahner, C., Peng, S., & Rizzolo, L. J. (2002) · The Journal of Membrane Biology · doi:10.1007/s00232-001-0137-7 · Cited by 51
Jin, J., Zhou, K. K., Park, K., Hu, Y., Xu, X., Zheng, Z., Tyagi, P., Kompella, U. B., & Ma, J.-X. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6229 · Cited by 48
Caldorera‐Moore, M. E., Ramirez, J. E. V., & Peppas, N. A. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1547732 · Cited by 45
In Vitro Gene Delivery in Retinal Pigment Epithelium Cells by Plasmid DNA-Wrapped Gold Nanoparticles
Trigueros, S., B. Domènech, E., Toulis, V., & Marfany, G. (2019) · Genes · doi:10.3390/genes10040289 · Cited by 45
Self-citationGene Editing Preserves Visual Functions in a Mouse Model of Retinal Degeneration
Vagni, P., Perlini, L. E., Chenais, N. A. L., Marchetti, T., Parrini, M., Contestabile, A., Cancedda, L., & Ghezzi, D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00945 · Cited by 45
Hessel, E., Herrmann, A., Müller, P., Schnetkamp, P. P. M., & Hofmann, K. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01147.x · Cited by 44
Phillips, L. C., Klibanov, A. L., Wamhoff, B. R., & Hossack, J. A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.020 · Cited by 44
Subretinal delivery of immunoglobulin G with gold nanoparticles in the rabbit eye
Hayashi, A., Naseri, A., Pennesi, M. E., & de Juan, E. (2009) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-009-0655-x · Cited by 43
Zhang, Y., Meng, S., Ding, J., Peng, Q., & Yu, Y. (2018) · The Analyst · doi:10.1039/c8an01620h · Cited by 43
Visual threshold is set by linear and nonlinear mechanisms in the retina that mitigate noise
Pahlberg, J., & Sampath, A. P. (2011) · BioEssays · doi:10.1002/bies.201100014 · Cited by 42
Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer
Browning, R. J., Able, S., Ruan, J.-L., Baù, L., Allen, P. D., Kersemans, V., Wallington, S., Kinchesh, P., Smart, S., Kartsonaki, C., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.020 · Cited by 41
Ochakovski, G. A., Peters, T., Michalakis, S., Wilhelm, B., Wissinger, B., Biel, M., Bartz-Schmidt, K. U., Fischer, M. D., & for the RD-CURE Consortium (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-22402 · Cited by 38
Retinal Gene Delivery by rAAV and DNA Electroporation
Venkatesh, A., Ma, S., Langellotto, F., Gao, G., & Punzo, C. (2013) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc14d04s28 · Cited by 35
Efficient mutagenesis of the rhodopsin gene in rod photoreceptor neurons in mice
Chan, F., Hauswirth, W. W., Wensel, T. G., & Wilson, J. H. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr196 · Cited by 34
Nonviral Gene Gun Mediated Transfer into the Beating Heart
Matsuno, Y., Iwata, H., Umeda, Y., Takagi, H., Mori, Y., Miyazaki, J., Kosugi, A., & Hirose, H. (2003) · ASAIO Journal · doi:10.1097/01.mat.0000093746.63497.ae · Cited by 32
Die Rolle des retinalen Pigmentepithels im Rahmen visueller Funktionen
Strauß, O. (2009) · Der Ophthalmologe · doi:10.1007/s00347-008-1869-x · Cited by 32
Educational paper: Retinal dystrophies and gene therapy
Sundaram, V., Moore, A. T., Ali, R. R., & Bainbridge, J. W. (2011) · European Journal of Pediatrics · doi:10.1007/s00431-011-1615-2 · Cited by 30
Ban, Y., Wilt, S. D., & Rizzolo, L. J. (2000) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00183-2 · Cited by 28
The polarity of the retinal pigment epithelium is developmentally regulated
Rizzolo, L. J., & Heiges, M. (1991) · Experimental Eye Research · doi:10.1016/0014-4835(91)90173-c · Cited by 28
Gene therapy for vision loss -- recent developments.
Stieger, K., & Lorenz, B. (2010) · PubMed · Cited by 27
Subretinal Delivery and Electroporation in Pigmented and Nonpigmented Adult Mouse Eyes
Nickerson, J. M., Goodman, P., Chrenek, M. A., Bernal, C. J., Berglin, L., Redmond, T. M., & Boatright, J. H. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-848-1_4 · Cited by 25
Tao, Y., Li, X.-X., Jiang, Y.-R., Bai, X.-B., Wu, B.-D., & Dong, J.-Q. (2007) · Current Drug Metabolism · doi:10.2174/138920007779815968 · Cited by 25
Effective delivery of recombinant proteins to rod photoreceptors via lipid nanovesicles
Asteriti, S., Cortivo, G. D., Pontelli, V., Cangiano, L., Buffelli, M., & Dell’Orco, D. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.088 · Cited by 23
Wan, C., Qian, J., Li, F., & Li, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3703 · Cited by 22
Li, T., Zhang, M., Han, Y. K., Zhang, H., Xu, L., & Xiang, Y. (2010) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-010-0661-8 · Cited by 20
CRISPR genome engineering for retinal diseases
Kantor, A., McClements, M. E., Peddle, C. F., Fry, L. E., Salman, A., Cehajic-Kapetanovic, J., Xue, K., & MacLaren, R. E. (2021) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2021.01.024 · Cited by 19
Self-citationDirect Cytosolic Delivery of siRNA Using Nanoparticle‐Stabilized Nanocapsules
Jiang, Y. Y., Tang, R., Duncan, B., Jiang, Z., Yan, B., Mout, R., & Rotello, V. M. (2014) · Angewandte Chemie · doi:10.1002/ange.201409161 · Cited by 19
In vivo electroporation to physiologically identified deep brain regions in postnatal mammals
Ohmura, N., Kawasaki, K., Satoh, T., & Hata, Y. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0724-x · Cited by 16
Sonoporation using microbubbles promotes lipofectamine -mediated siRNA transduction to rat retina.
Zheng, X.-Z., Ji, P., & Hu, J. (2011) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2011.2565 · Cited by 16
Polyethylenimine Functionalized Ultrasmall Mesoporous Silica Nanoparticles for siRNA Delivery
Chang, Q., Liu, C., Xie, Z., Shu, Q., Xie, Y., Su, Q., & Deng, X. (2022) · ChemNanoMat · doi:10.1002/cnma.202100453 · Cited by 13
Mouse Retina Has Oligonucleotide-Induced Gene Repair Activity
Ciavatta, V. T., Padove, S. A., Boatright, J. H., & Nickerson, J. M. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1220 · Cited by 9
DNA Delivery in Adult Mouse Eyes: An Update with Corneal Outcomes
Nickerson, J. M., Getz, S. E., Sellers, J. T., Chrenek, M. A., Goodman, P., Bernal, C. J., & Boatright, J. H. (2014) · Methods in molecular biology · doi:10.1007/978-1-4614-9632-8_15 · Cited by 8
Precision delivery of RAS-inhibiting siRNA to pancreatic cancer via peptide-based nanoparticles.
Strand, M. S., Pan, H., Krasnick, B. A., Zhang, X., Goedegebuure, P. S., Fleming, T. P., DeNardo, D. G., Gillanders, W. E., Hawkins, W. G., Wickline, S. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.4_suppl.287 · Cited by 6
Correction: Sonoporation by microbubbles as gene therapy approach against liver cancer
Rinaldi, L., Folliero, V., Palomba, L., Zannella, C., Isticato, R., Francia, R. D., Berretta, M., de Sio, I., Adinolfi, L. E., Morelli, G., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26305 · Cited by 1
Cited by
Overview of Recent Advances in Nano-Based Ocular Drug Delivery
Liu, L.-C., Chen, Y., & Lu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015352 · Cited by 173
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Dubey, A. K., & Mostafavi, E. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1259435 · Cited by 103
In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
Huang, K. L., Zapata, D. A., Tang, Y., Teng, Y., & Li, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121876 · Cited by 66
Nanoplatform‐Based In Vivo Gene Delivery Systems for Cancer Therapy
Luo, R., Le, H., Wu, Q., & Gong, C. (2024) · Small · doi:10.1002/smll.202312153 · Cited by 53
Recent advances in carbon monoxide-releasing nanomaterials
Ning, X., Zhu, X., Wang, Y., & Yang, J. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.03.001 · Cited by 51
Metadata
- Authors
- Salman, A., Kantor, A., McClements, M. E., Marfany, G., Trigueros, S., & MacLaren, R. E.
- Affiliations
- University of Oxford (GB)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Department of Genetics Microbiology and Statistics, University of Barcelona, 08007 Barcelona, Spain
- Corresponding author
- Salman, Ahmed
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2022-09-01
- Volume
- 14
- Issue
- 9
- Pages
- 1842
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC9503525
- OpenAlex
- W4294169508
- Cited by
- 37
- References
- 192
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 8 · 2023: 10 · 2022: 2
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- NIHR Oxford Biomedical Research Centre
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- CRISPR-Cas, non-viral delivery, nanoparticles, retina, ocular gene therapy, gene therapy vectors, blood-retinal barrier, nanomaterials, genome editing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.